HomeAboutusEditorial BoardCurrent issuearchivesSearch articlesInstructions for authorsSubscription detailsAdvertise

  Login  | Users online: 696

   Ahead of print articles    Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size  

SHORT COMMUNICATION Table of Contents   
Year : 2021  |  Volume : 46  |  Issue : 4  |  Page : 727-730
Association of bacillus calmette guerin vaccine strains with COVID-19 morbidity and mortality – evaluation of global data

Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharshtra, India

Correspondence Address:
Dr. Vijaya Laxman Chaudhari
Department of Clinical Pharmacology, First Floor, New MS Building, Seth GS Medical College and KEM Hospital, Parel, Mumbai - 400 012, Maharashtra
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijcm.IJCM_103_21

Rights and Permissions

Background: Literature suggests that the presence of the current Bacillus Calmette Guerin (BCG) policy appears to mitigate COVID-19 disease burden but no information exists on the nature of the BCG strain and disease burden. Objectives: To study the association between type of BCG strain, BCG coverage (%), and COVID-19 disease burden. Methodology: An audit of global data on strains and disease burden was done. Country-specific data for COVID-19 cases and deaths, BCG-related data, and income level were obtained from the online databases, and the association was analyzed using linear regression. Results: Data of 139 countries were studied and 117 (84%) had a current BCG policy. Data on BCG strains were available for 51 countries and 18/51 (35%) used the Danish strain. While the choice of strain did not impact COVID-19-related disease burden, the presence of a current BCG policy was significantly associated with lower COVID-19 mortality. Conclusion: The presence of current BCG policy is associated with decreased COVID-19-related disease burden, but the type of strain used by a country in its vaccination program does not impact disease burden.

Print this article  Email this article

  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
   Citation Manager
  Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded44    
    Comments [Add]    

Recommend this journal


  Sitemap | What's New | Feedback | Copyright and Disclaimer
  2007 - Indian Journal of Community Medicine | Published by Wolters Kluwer - Medknow
  Online since 15th September, 2007